Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):O1
Volume 4 Supplement 3
Publication of this supplement was funded by the European Academy of Allergy and Clinical Immunology (EAACI).
6th Drug Hypersensitivity Meeting (DHM 6). Go to conference site.
Bern, Switzerland9-12 April 2014
Page 1 of 4